Valuation: Macrogen, Inc.

Market Cap 132B 98.22M 87.71M 81.83M 74.33M 140M 9.51B 141M 982M 384M 4.83B 369M 361M 15.55B P/E 2024
-21.7x
P/E 2025 90.2x
Enterprise Value 182B 136M 121M 113M 103M 193M 13.15B 195M 1.36B 531M 6.68B 510M 499M 21.48B EV / Sales 2024
1.49x
EV / Sales 2025 1.19x
Free-Float
79.78%
Yield 2024
1.82%
Yield 2025 2.96%
1 day-2.33%
1 week-0.33%
Current month-0.33%
1 month-0.41%
3 months-2.17%
6 months-21.92%
Current year-27.80%
1 week 12,110
Extreme 12110
12,690
1 month 11,500
Extreme 11500
12,790
Current year 10,440
Extreme 10440
20,900
1 year 10,440
Extreme 10440
20,900
3 years 10,440
Extreme 10440
26,700
5 years 10,440
Extreme 10440
31,250
10 years 10,440
Extreme 10440
54,900
Manager TitleAgeSince
Chief Executive Officer 59 31/03/2025
Chief Executive Officer 74 31/03/2025
Director of Finance/CFO 52 -
Director TitleAgeSince
Chairman 74 10/10/2010
Director/Board Member 59 -
Director/Board Member 53 31/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
09/04/25 Buy

Chief Executive Officer

1,100 0.0101%
07/02/25 Others 2,192 0.0202%
23/01/25 Others

Chief Financial Officer

95 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-0.33%-21.37%-31.53% 101M
-3.19%-3.19%+44.60%+87.98% 74.68B
-15.86%-16.67%+3.92%+50.90% 58.7B
-2.39%-2.05%+4.29%+31.33% 48.36B
-6.35%-8.63%+293.39%+638.59% 43.05B
+0.30%-0.71%+29.05%+29.74% 42.48B
-3.82%-2.41%-0.27%+102.63% 41.39B
-2.13%+1.07%+7.51%+50.31% 31.29B
-3.35%-4.95%-13.38%-15.78% 23.93B
-1.24%-7.47%-37.90%+309.96% 22.22B
Average -4.02%-2.76%+30.99%+125.41% 38.62B
Weighted average by Cap. -4.84%-1.88%+43.23%+135.05%

Financials

2024 2025
Net sales 136B 101M 90.19M 84.14M 76.43M 144M 9.78B 145M 1.01B 395M 4.97B 379M 371M 15.99B 195B 145M 130M 121M 110M 207M 14.07B 209M 1.45B 568M 7.15B 545M 534M 22.99B
Net income -7.6B -5.66M -5.05M -4.71M -4.28M -8.05M -548M -8.13M -56.57M -22.12M -278M -21.23M -20.77M -895M 2.03B 1.51M 1.35M 1.26M 1.14M 2.15M 146M 2.17M 15.1M 5.91M 74.31M 5.67M 5.55M 239M
Net Debt 38.17B 28.39M 25.36M 23.65M 21.49M 40.43M 2.75B 40.83M 284M 111M 1.4B 107M 104M 4.49B 50.44B 37.52M 33.5M 31.26M 28.39M 53.43M 3.63B 53.95M 375M 147M 1.85B 141M 138M 5.94B
Projected Income Statement - Annual - Macrogen, Inc.
Logo Macrogen, Inc.
Macrogen Inc is a Korea-based company principally engaged in the genome analysis business. The Company’s main products include DNA sequencing, oligo synthesis, and microarray analysis. The Company also provides various genome-based research services such as single-cell analysis and metagenome analysis. In addition, the Company is engaged in the operation of genetically engineered mouse production, clinical genome analysis services, personal genome analysis services, and microbiome analysis services. The Company sells its products and services in domestic and overseas markets.
Employees
473
Date Price Change Volume
08/10/26 ₩12,180.00 -2.33% 20,372
07/10/26 ₩12,470.00 -0.64% 29,293
06/10/26 ₩12,550.00 -0.32% 20,315
02/10/26 ₩12,590.00 -0.71% 13,735
01/10/26 ₩12,680.00 +3.76% 24,417

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Macrogen, Inc.
  1. Stock Market
  2. Stocks
  3. A038290 Stock